Vertex to Present at Upcoming Investor Conferences

BOSTON–(BUSINESS WIRE)– Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that
management will present at The Morgan Stanley Global Healthcare
Conference in New York, NY on Wednesday, September 14^th at
11:40 a.m. ET. Vertex will also present at The Leerink Partners
Roundtable Series in New York, NY on Wednesday, September 28^th
at 3:40 p.m. ET.

Management’s remarks will be accessible live through Vertex’s website at www.vrtx.com in
the « Investors » section under the « Events and Presentations » page. A
replay of the conference webcast will be archived on the company’s
website.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop
and commercialize innovative medicines so people with serious diseases
can lead better lives. In addition to our clinical development programs
focused on cystic fibrosis, Vertex has more than a dozen ongoing
research programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Cambridge, Mass., Vertex today has research and
development sites and commercial offices in the United
States, Europe, Canada and Australia. For five years in a row, Science magazine
has named Vertex one of its Top Employers in the life sciences. For
additional information and the latest updates from the company, please
visit www.vrtx.com.

(VRTX-GEN)

View source version on businesswire.com: http://www.businesswire.com/news/home/20160909005889/en/